Project Grant R21CA299799
Award Date
6/1/25
Completion Date
5/31/27
Dollars Obligated
$403K
Federal Agency
National Cancer Institute
Federal Grant Program
93.395
Assistance Type
Project Grant
Place of Performance
Maryland, USA
Similar Awards
The National Center for Complementary and Integrative Health (NCCIH) awarded Ralphvr Inc. a $254,892 Project Grant under the Research and Training in Complementary and Integrative Health program (CFDA 93.213). The funding supports the development and feasibility testing of "Virtual Partner", a multi-component virtual reality (VR) application designed to reduce delirium in intensive care unit (ICU) patients. The project aims to 1) conduct focus groups with ICU staff and former...
This $2,302,407 federal Project Grant award from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) will fund a randomized controlled trial to test the efficacy of an immersive mindfulness virtual reality (VR) intervention for improving pain and reducing illicit opioid use among individuals with chronic pain and opioid use disorder (OUD) enrolled in opioid treatment programs in the Bronx, New York. The primary objectives are to evaluate...
This Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), aims to conduct a pilot randomized controlled trial to test the clinical impact and feasibility of a virtual reality (VR) cognitive behavioral therapy (CBT) program for patients with irritable bowel syndrome (IBS). The $334,000 award to Cedars-Sinai Medical Center will be used to develop and...
This federal Project Grant award of $621,732 from the National Cancer Institute (NCI) under the Cancer Cause and Prevention Research program (CFDA 93.393) will fund a hybrid effectiveness-implementation trial to evaluate a proactive identification and digital mental health intervention approach to address unmet psychosocial needs of individuals living with likely incurable cancer. The key products and services to be delivered under this 5-year grant include: 1) comprehensively assessing the...
This federal Project Grant award of $732,536.00 from the National Cancer Institute's Cancer Treatment Research program (CFDA 93.395) will fund the Enhanced Pain Coping in Cancer (EPIC) study. The EPIC study aims to evaluate the efficacy of a mindfulness-based intervention called Mindfulness-Oriented Recovery Enhancement (MORE) for managing aromatase inhibitor-associated arthralgia (AIA), a chronic pain condition affecting breast cancer survivors. The study will randomize 200 breast cancer...
The federal Project Grant award of $578,284 from the National Cancer Institute (NCI), under the Cancer Cause and Prevention Research (CFDA 93.393) program, supports a mixed-methods study on the impact of state cannabis laws on cancer pain management and outcomes. The study, conducted by Duke University, aims to evaluate the effects of state cannabis laws on pain management practices (e.g., opioid therapy) and outcomes (e.g., treatment for opioid and cannabis use disorder, patient-reported...
This Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), is for the development and demonstration of a prototype system called "Stimulant Use Recovery via Immersive Virtual Environments (SURVIVE)." The goal is to design a virtual reality-based system that can provide controlled environmental triggers and cognitive behavioral therapy (CBT) content to supplement current treatment practices for stimulant...
The National Cancer Institute (NCI) awarded a $577,778 Project Grant under the Cancer Cause and Prevention Research (CFDA 93.393) federal grant program to Virginia Commonwealth University (VCU) to investigate the feasibility and acceptability of the FEARLESS intervention for patients with primary malignant brain tumors and their caregivers. The proposed study is a Phase IIb randomized waitlist-controlled trial that aims to address key information gaps regarding recruitment strategies, target...
This $349,333 Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) supports the development and feasibility testing of a virtual reality (VR) platform called "VR-CARES" to provide social support and enrichment for in-home dementia caregivers. The key products and services to be delivered through this STTR Phase I study include: Co-developing the VR-CARES platform with input from dementia caregivers to ensure it aligns with their needs and experiences....
This federal Project Grant award from the National Cancer Institute (CFDA 93.393 - Cancer Cause and Prevention Research) totaling $1,239,420.00 supports a longitudinal observational study to assess the role of interoception (the brain's processing of bodily sensations) in chemotherapy-induced peripheral neuropathy (CIPN) among 120 cancer patients receiving taxane or platinum chemotherapy. The study, conducted by the University of Maryland, Baltimore, will include functional brain imaging,...